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176Objective: Interrupted aortic arch is a rare congenital anomaly affecting 1.5% of infants with congenital heart
disease. Multiple surgical modalities exist to address this defect. We evaluate the long-term outcome of inter-
rupted aortic arch with the left carotid artery turndown technique from a single institution.
Methods: Patients with interrupted aortic arch who underwent the carotid turndown procedure were identified
between September 1982 and March 2010. Medical and surgical records were reviewed. Mortality data were
obtained from state death records.
Results: Forty-seven patients met inclusion criteria. Median follow-up was 6.2 years (5 days to 23.2 years).
Twenty-one patients (45%) had genetic syndromes. There were 4 operative deaths (8.5%) and 9 late deaths
(19%). One-year and 5-year survivals were 80.2% and 72.6%, respectively. Seventeen patients (36.2%) re-
quired reoperation or other interventions on the aortic arch.
Conclusions: Left carotid artery turndown offers a favorable surgical outcome. It compares with end-to-end re-
pair, while providing a tension-free anastomosis and avoiding neonatal circulatory arrest and cardiopulmonary
bypass. Disadvantages include a 2-stage repair and a significant reintervention rate, particularly when compared
with the aortic arch advancement technique. Nevertheless, the reduced exposure to circulatory arrest and bypass
and avoidance of left bronchial obstruction are important considerations that may offset these limitations.
(J Thorac Cardiovasc Surg 2013;145:176-82)Interrupted aortic arch (IAA), first described by Steidele in
1778,1 is a rare cardiac anomaly in which discontinuity ex-
ists between the ascending and descending aortas.2 IAA
accounts for approximately 1.5% of all infants with con-
genital heart disease, and without medical intervention, its
natural history results in an 80% mortality rate during the
first month of life.2 Medical management was revolu-
tionized with the introduction of prostaglandin E1 in
1976.3,4
Since the first surgical repair in 1955, multiple techniques
have been used.5 Regardless of method, reintervention is
frequently required to address recurrent aortic arch obstruc-
tion.6 Other significant sources of reintervention include
left ventricular outflow tract obstruction7 and left bronchial
compression.8
At the Indiana University School of Medicine, the pri-
mary method of IAA repair has been the left carotid artery
turndown (LCATD) technique. The aim of this study was toe Department of Pediatrics (Cardiology)a and Department of Cardiovascular
horacic Surgery,b Indiana University School of Medicine, Indianapolis, Ind.
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and to compare this method with other reported surgical
modalities.
MATERIALS AND METHODS
All patients with the diagnosis of IAAwho underwent repair by LCATD
at the James W. Riley Hospital for Children between September 1982 and
July 2009 with follow-up through June 2010 were identified after institu-
tional review board approval. Hospital medical and surgical records were
reviewed, as well as the medical and surgical records from the divisions
of pediatric cardiology and cardiothoracic surgery. Data collected include
patient demographics, nature of cardiac disease and associated syndromes,
surgical and catheterization reports, echocardiograms, and clinical follow-
up. Additional information regarding mortality was obtained through state
death records. Operative mortality was defined as any death occurring
within 30 days of the carotid turndown procedure or after 30 days during
the same hospitalization. Subsequent deaths were defined as late mortality.
Survival time was defined as elapsed time since the date of surgery until
death or day of last follow-up. The Celoria and Patton classification was
used to determine IAA type.9
Surgical Procedure
Reconstruction of the aortic arch by the LCATD is performed by anas-
tomosing the divided and spatulated end of the distal left carotid artery to
the descending aorta, with division and excision of the patent ductus arte-
riosus via a left thoracotomy. Pulmonary artery (PA) banding also is per-
formed as part of this staged approach.10
After the left carotid artery, transverse aortic arch, left subclavian artery,
and ductus arteriosus are circumferentially dissected, the descending tho-
racic aorta is mobilized distally for 4 to 6 pairs of intercostal arteries.
The left common carotid artery is then mobilized as far cranially as possi-
ble, and the ductus arteriosus is ligated and divided, with removal of ductal
tissue from the distal aortic arch. The left common carotid artery is thenery c January 2013
Abbreviations and Acronyms
CHSS ¼ Congenital Heart Surgeons’ Society
CI ¼ confidence interval
IAA ¼ interrupted aortic arch
LCATD ¼ left carotid artery turndown
PA ¼ pulmonary artery
VSD ¼ ventricular septal defect
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Ddivided, spatulated, and anastomosed to the descending thoracic aorta with
absorbable suture, as shown in Figure 1.10
The second stage of the procedure (typically 3-9 months later) com-
prises patch closure of the ventricular septal defect (VSD), repair of any ad-
ditional intracardiac defects, PA debanding, and PA reconstruction with
polytetrafluoroethylene or autologous pericardial patch.10 In complex con-
genital heart disease, particularly with single ventricle anatomy, alternate
procedures are used as indicated for the subsequent stages.
Statistical Analysis
Survival and freedom from arch reintervention curves were constructed
using the Kaplan–Meier product limit method and various percentiles, and
95% confidence intervals (CIs) were calculated. Freedom from reinterven-
tion was calculated as the elapsed time since the date of surgery to the date
of reintervention. Subjects who died or were lost to follow-up before rein-
tervention were censored at the time of death or date of last follow-up. Uni-
variate Cox proportional hazards models were used to compare the various
curves between eras of surgery and to evaluate various risk factors for late
survival.
RESULTS
Forty-seven neonates and infants met inclusion criteria
for the study. The median postoperative follow-up was 8.2
years (95% CI, 6.2-12.2; range, 5 days to 23.2 years).
Thirty patients (64%) were male. Mean birth weight was
3.0 kg  0.6 kg. Genetic syndromes were diagnosed in 21
patients (45%), with DiGeorge in 19 (40%) and VACTERL
association (disorder that involves abnormalities of the ver-
tebrae, anus, heart, trachea, kidneys and limbs) in 2 (4%).
Forty-six patients (98%) were classified as IAA type B,
with 1 patient classified as IAA type A. The most common
associated structural cardiac anomaly was a VSD, which
was present in 46 patients (98%). Twenty-seven patients
(57%) had an atrial septal defect. Nineteen patients
(40%) had a bicuspid or unicommisural aortic valve.
Twelve patients (26%) had subaortic stenosis, and 3 pa-
tients (6%) had aortic valve stenosis. Two patients (4%)
had Taussig–Bing double-outlet right ventricle, and 3 pa-
tients (6%) had an aberrant right subclavian artery. Baseline
demographic data and associated structural cardiac anoma-
lies are detailed in Table 1.
Mortality
Outcome evaluation for the first-stage LCATD procedure
demonstrated no intraoperative deaths. Thirty-day survival
for all patients was 95.7% (95% CI, 83.9-98.9). There
were 13 (28%) total deaths in our patient cohort, includingThe Journal of Thoracic and Ca2 intraoperative deaths during subsequent surgeries. Ten of
13 patients had IAA with a VSD or multiple VSDs. Three
patients had complex lesions, including double-inlet left
ventricle with ventricular inversion, dextro-transposition of
the great arteries, and truncus arteriosus. Figure 2 illustrates
the Kaplan–Meier survival for all patients. One-year, 5-year,
and 15-year survivals for all patients were 80.2% (95% CI,
65.4-89.2), 72.6% (95% CI, 56.6-83.5), and 67.4% (95%
CI, 49.0-80.5), respectively. To determine whether there
was as difference in mortality according to the date of sur-
gery, the years of surgery were dichotomized at the median
value into 2 eras: 1982 to 1995 and 1996 to 2009
(Figure 3). There were 6 (46%) deaths in patients in the first
era and 7 (54%) deaths in patients after 1995 (P ¼ .62).
Four patients were classified as operative mortalities
(8.5%). Bacterial sepsis developed in 1 patient, who died
5 days after LCATD. One patient died 10 days after LCATD
during a subsequent surgery that included a Damus–Kaye–
Stansel procedure, subaortic resection, and placement of
a Sano-type right ventricle to PA conduit. The surgery
was uneventful, with good hemodynamics maintained
throughout the operation; however, there was significant re-
sidual transverse aortic arch obstruction at the end of the
procedure. Given the extensive dissection at the site and
the prior use of the carotid artery for aortic arch reconstruc-
tion, the surgeon determined that no further augmentation
was possible; the patient was weaned from cardiopulmo-
nary bypass and died shortly thereafter. One patient died
1.3 months after LCATD secondary to a central line infec-
tion and never achieved hospital discharge. One patient died
5.6 months after LCATD secondary to respiratory failure.
This patient had VACTERL association with tracheoeso-
phageal fistula and bronchomalacia. In addition to the 4 pa-
tients who experienced operative mortality, 1 patient was
lost to follow-up after hospital discharge 8 days after sur-
gery. There were 9 late mortalities after the patient lost to
follow-up was excluded from the late survival analysis.
Mortality data are described in Table 2. Censoring the sur-
vival data for these patients demonstrates similar findings.
Univariate analysis for various risk factors, including
gender, birth weight, age at surgery, and genetic syndrome,
did not identify significant associations with late mortality.
Thirty-two patients underwent the second-stage repair
that included VSD closure and PA debanding at 1.7  2.3
years after LCATD surgery (median, 0.9 years; range,
0.03-10.1 years). There were 2 operative mortalities associ-
ated with the second-stage surgery. By combining the 2
stages, operative mortality for this lesion was 12.8%. In 1
patient with truncus arteriosus after PA band removal,
VSD closure, and placement of a 12-mm aortic homograft
right ventricle to PA conduit, the patient could not beweaned
from cardiopulmonary bypass and died on the operative ta-
ble. The second patient underwent PA band removal and
VSD closure and was placed on extracorporeal membranerdiovascular Surgery c Volume 145, Number 1 177
FIGURE 1. Left carotid artery turndown procedure. Ao, Aorta; LCA, left coronary artery; LSCA, left subclavian artery; PA, pulmonary artery; RCA, right
coronary artery; RSCA, right subclavian artery.
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ondary to low-output heart failure. These surgeries occurred
2.3 and 3.3 months after LCATD surgery, respectively.
Reintervention and Reoperation
Seventeen patients (36.2%) underwent surgical or inter-
ventional cardiac catheter–based aortic arch reinterven-
tions, comprising angioplasty or placement of an
endovascular stent. There were 8 surgical and 10 nonsurgi-
cal reinterventions, with 1 patient undergoing a surgical re-
intervention followed 9.5 years later by a catheter-based
aortic arch intervention. Figure 4 illustrates the Kaplan–
Meier freedom from aortic arch reintervention or reopera-
tion data for all patients. The 30-day freedom from any
type of arch reintervention or reoperation was 97.7%
(95% CI, 84.9-99.7) The 1-year and 15-year freedom
from aortic arch reintervention or reoperation was 63.6%
(95% CI, 46.9-76.3) and 57.4% (95% CI, 40.2-71.2), re-
spectively. There was no difference in survival when seg-
mented into surgical era (P ¼ .23).
No patients in our series had left bronchial compression.
Subaortic stenosis that required a subaortic membrane re-
section occurred in 6 patients (12.8%) 1.4 1.0 years after
LCATD surgery (median, 1.2 years; range, 0.46-3.07
years). Of these, the subaortic stenosis was identified in 2
patients before LCATD surgery. Evidence of subaortic178 The Journal of Thoracic and Cardiovascular Surgstenosis after PA banding developed in 4 patients, who un-
derwent subaortic resection at the time of the second-stage
surgery. No subaortic resections occurred after the second-
stage surgery.
Children who underwent LCATD and achieved hospital
discharge were inpatients 29.2  28.9 days (median, 19
days; range, 7-138 days) from LCATD surgery. One patient
underwent truncus arteriosus repair 4 days after LCATD
surgery and was discharged from the hospital 21 days after
LCATD surgery.
DISCUSSION
The optimal surgical technique to repair IAA remains
a matter for debate. Although the Indiana University School
of Medicine prefers the LCATD technique, many centers
use primary anastomosis or aortic arch advancement.11-13
Likewise, the Indiana University School of Medicine uses
primary repair for more complex lesions, including
dextro-transposition of the great arteries, truncus arteriosus,
and hypoplastic left heart syndrome.
In the primary anastomosis technique, the ascending
aorta and its branches are mobilized along with the ductus
arteriosus and descending aorta via a median sternotomy.
The ductus is ligated and divided after commencing cardio-
pulmonary bypass, and ductal tissue is excised. One or 2 pe-
riods of hypothermic circulatory arrest may be required,ery c January 2013
TABLE 1. Patient characteristics: Mean ± standard deviation or
n (%)
Total (n ¼ 47)
Male 30 (63.8%)
Body weight (kg) 3.0  0.6
Type of aortic arch interruption
Type A 1 (2.1%)
Type B 46 (97.9%)
Type C 0 (0%)
Associated structural cardiac anomalies
Patent ductus arteriosus 47 (100%)
VSD 46 (97.9%)
Atrial septal defect 27 (57.4%)
Bicuspid or unicommisural aortic valve 19 (40.4%)
Subaortic stenosis 12 (25.5%)
Aortic stenosis 3 (6.4%)
Aberrant right subclavian artery 3 (6.4%)
Truncus arteriosus 2 (4.3%)
Taussig–Bing DORV 2 (4.3%)
Double-inlet left ventricle 2 (4.3%)
Hypoplastic right ventricle 1 (2.1%)
Double-outlet right ventricle 1 (2.1%)
Hypoplastic left ventricle 1 (2.1%)
L-transposition of the great arteries 1 (2.1%)
D-transposition of the great arteries 1 (2.1%)
Mitral atresia 1 (2.1%)
Vascular ring 1 (2.1%)
VSD, Ventricular septal defect; DORV, double-outlet right ventricle.
FIGURE 3. Kaplan–Meier survival curve for all patients (stratified
by era).
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sociated intracardiac defects.14 Proponents of this approach
endorse the advantage that it allows for adequate growth po-
tential of the aortic arch.15 In addition, the midline approach
enables a complete, 1-stage repair, allowing for repair of as-
sociated cardiac anomalies.
Postoperative complications with this procedure are well
documented. Bronchial compression may result from ten-
sion at the anastomotic site secondary to inadequateFIGURE 2. Kaplan–Meier survival for all patients.
The Journal of Thoracic and Camobilization of the aorta.6,13,16 The increased posterior
and inferior traction of the aorta on the left main bronchus
have necessitated aortopexy or placement of an
interposition graft.16,17 Bleeding also is more likely in the
postoperative period because of increased tension of the
aortic arch anastomosis.14 Reports, including the latest
472 patient multi-institutional Congenital Heart Surgeons’
Society (CHSS) study, have suggested that the direct anas-
tomosis technique results more frequently in aortic arch
obstruction compared with other methods of repair.12,18,19
The reported incidence of persistent or recurrent arch
obstruction ranges from 0% to 50%.
A recent report describes a new technique for IAA inwhich
the anterior wall of the PA is excised and tailored to reestab-
lish aortic continuity with an autologous tube.20 It has been
referred to as the ‘‘Neville tube.’’ Outcomes of this technique
will warrant consideration as more experience is acquired.
We report a 15-year freedom from aortic arch reinterven-
tion rate of 57.4% that is comparable to a recent report by
Hussein and colleagues,21 who described a 51% freedom
from aortic arch obstruction in the setting of direct end-
to-side anastomosis. However, Morales and colleagues22 re-
ported a 5-year freedom from aortic arch reintervention rate
of 100%with the aortic arch advancement technique. Their
study used an actuarial method for the statistical analysis.
By using a Kaplan–Meier estimation method but excluding
nonsurvivors, our 5-year freedom from reintervention rate
is 66.3% (95% CI, 47.4-79.7).
The LCATD technique presents some advantages over
direct anastomosis. By providing a tension-free anastomo-
sis, bronchial compression is avoided, as seen in this series.
Nevertheless, bronchial compression was avoided in the
arch advancement series reported by Morales and col-
leagues.22 This was achieved with extensive mobilization
of the descending aorta. In addition, we report a 13% inci-
dence of subaortic resection at the time of the second-stagerdiovascular Surgery c Volume 145, Number 1 179
TABLE 2. Mortality data
Diagnoses
Timing
of death Cause
Age at
death
(mo)
Time from
LCATD
(mo) Last surgery
Time from
last surgery
(mo)
Hospital
discharge
after LCATD
IAA-B, VSD,
DiGeorge
syndrome
Operative Sepsis 0.39 0.16 LCATD; PAB 0.16 No
IAA-B, VSD Operative Intraoperative death;
severe residual arch
obstruction; low-output
heart failure
0.66 0.33 DKS Sano 0.00 No
IAA-B, VSD, DILV,
L-TGA, hypoplastic AA
Operative Central line infection 1.48 1.31 LCATD; PAB 1.31 No
IAA-B, VSD Late Low-output heart failure
(ECMO)
3.48 3.25 VSD, PAB removal,
recoarctation
patch augmentation
0.13 Yes
IAA-B, VSD Late Respiratory failure 4.01 3.91 LCATD; PAB 3.91 Yes
IAA-B, VSD, truncus
arteriosus
Late Intraoperative death;
low-output heart failure
4.04 3.94 PAB removal,
truncus repair
1.68 Yes
IAA-B, VSD, VACTERL
association
Operative Respiratory failure 5.75 5.55 LCATD; PAB 5.55 No
IAA-B, VSD, DiGeorge
syndrome
Late Pneumonia 6.97 6.90 VSD, PAB removal 2.17 Yes
IAA-B, VSD, DiGeorge
syndrome
Late Pneumonia 10.02 9.86 VSD, PAB removal,
PFO closed
5.78 Yes
IAA-B, multiple VSDs,
DiGeorge syndrome
Late Sepsis 25.99 25.89 VSD, PAB removal 14.49 Yes
IAA-B, VSD, DILV, D-TGA Late Respiratory failure 30.19 30.06 Extracardiac Fontan 2.66 Yes
IAA-B, VSD Late Sudden death 59.76 58.38 VSD, PAB removal 45.14 Yes
IAA-B, VSD, DORV,
subaortic stenosis
Late Transplant rejection 118.51 118.47 Heart transplant 10.35 Yes
LCATD, Left carotid artery turndown procedure; IAA-B, interrupted aortic arch type B; VSD, ventricular septal defect;DILV, double-inlet left ventricle; L-TGA, L-transposition of
the great arteries; AA, aortic arch; VACTERL, disorder that involves abnormalities of the vertebrae, anus, heart, trachea, kidneys and limbs; D-TGA, D-transposition of the great
arteries;DORV, double-outlet right ventricle; ECMO, extracorporeal membrane oxygenation; PAB, pulmonary artery banding;DKS Sano,Damus–Kaye–Stansel with Sano mod-
ification; PFO, patent foramen ovale.
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Drepair. Prior studies have reported rates of reoperation for
left ventricular outflow obstruction from 18% to
34%.22,23 A strategy we use to reduce the risk ofFIGURE 4. Freedom from aortic arch reintervention or reoperation (all
patients).
180 The Journal of Thoracic and Cardiovascular Surgsubaortic obstruction is to limit the time of PA banding to
between 3 and 9 months when possible. Although 7
outliers underwent PA debanding more than 2 years after
the initial surgery because of conditions such as
pulmonary hypertension, 20 (66%) underwent the
second-stage surgery within 1 year of the LCATD. Patients
who underwent subaortic resection completed the second
stage 1.6  0.9 years after LCATD.
The avoidance of circulatory arrest and cardiopulmonary
bypass in the neonatal period is perhaps the most important
consideration with the LCATD technique. In a recent anal-
ysis of neonates with IAA who underwent surgical repair,
longer circulatory arrest times predicted lower mental de-
velopment.24 Regional perfusion techniques have been as-
serted as improvements to circulatory arrest with respect
to neurodevelopmental outcomes25-27; however, recent
studies have not demonstrated differences between the 2
modalities.28-30 Although neurologic outcomes were not
a primary end point in our study, a lack of neurologic
deficits, seizures, and growth disturbances has been
described in prior reports using the LCATD technique.10ery c January 2013
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technique are 91% and 72%, respectively. The aforemen-
tioned single-stage experience reported byMorales and col-
leagues22 describes comparable survival, with 30-day
survival at 93% and 5-year survival at 76%. Mainwaring
and Lamberti23 report a 2-stage approach with 1- and
5-year survival at 85% and 81%, respectively. The late sur-
vival reported in the CHSS study is similar at 67%, which
included IAA types A and B. The CHSS reported a 56%
late survival for patients with type B, which was the IAA
type in all but 1 patient in our series.18 Their analysis impor-
tantly identified IAA type B as an independent risk factor
for mortality. It was of interest that although this subgroup
made up 70% of the CHSS patient population, IAA type B
represented 97.9% of our population.
Study Limitations
This is a retrospective review that covers more than 25
years. Although continued experience with a procedure
may lead to significant changes in outcome over time, we
demonstrated no significant change in outcome when ac-
counting for different surgical eras. Direct comparison
with other surgical modalities for this disease is limited be-
cause our center has favored the LCATD for IAA in greater
than 95% of cases. As such, the primary mode of compar-
ison is to compare outcomes with those of other centers, as
reported in this study.
A potential disadvantage of this procedure is the sacrifice
of 1 carotid artery. Although no complications of this have
been directly observed, more specific evaluation of this el-
ement would be warranted. It is important to also recognize
that this approach requires 2 surgeries compared with the
more common single-stage approach. Nevertheless, a sec-
ond surgery is frequently required in single-stage repair
for subaortic stenosis, reported at 18% to 34% in some se-
ries.22,23 In our series, we present 2 additional operative
mortalities that occurred relative to the second-stage sur-
gery. Despite this additional operative risk, the intention
of the 2-stage approach in our center is to limit cardiopul-
monary bypass exposure in the newborn period with out-
comes comparable to the single-stage approach.
CONCLUSIONS
The optimal method for aortic arch repair will likely con-
tinue to be unresolved without a multicenter randomized
controlled trial. This study represents the largest reported
series of the LCATD technique. Our data demonstrate that
the LCATD technique has operative and late survivals for
IAA type B that are similar to those for other reported
methods. Although there still remains a significant reinter-
vention rate for recurrent arch obstruction, the intervention
rate for subaortic obstruction was low at 13% in our series
compared with the 25% to 40% subaortic obstruction rate
reported in other series.12 We contend that the reducedThe Journal of Thoracic and Caexposure to circulatory arrest and cardiopulmonary bypass
in the newborn period and lower incidence of bronchial
compression and reoperation for subaortic resection offset
the higher reintervention rate andmake this a reasonable ap-
proach to IAA repair.
The authors thank Katie Lane for the statistics expertise and as-
sistance with the Biomedical Statistics department at Indiana
University.
References
1. Steidele RJ. Samml Chir u Med Beob (Vienna). 1778;2:114.
2. Van Praagh R, BernhardWF, Rosenthal A, Parisi LF, Fyler DC. Interrupted aortic
arch: surgical treatment. Am J Cardiol. 1971;27:200-11.
3. Lang P, FreedMD,RosenthalA, CastanedaAR,NadasAS. The use of prostaglan-
din e1 in an infant with interruption of the aortic arch. J Pediatr. 1977;91:805-7.
4. Olley PM, Coceani F, Bodach E. E-type prostaglandins: a new emergency therapy for
certain cyanotic congenital heart malformations. Circulation. 1976;53:728-31.
5. Merrill DL, Webster CA, Samson PC. Congenital absence of the aortic isthmus;
report of a case with successful surgical repair. J Thorac Surg. 1957;33:311-20.
6. Tlaskal T, Hucin B, Hruda J, Marek J, Chaloupecky V, Kostelka M, et al. Results
of primary and two-stage repair of interrupted aortic arch. Eur J Cardiothorac
Surg. 1998;14:235-42.
7. Schreiber C, Eicken A, Vogt M, Gunther T, Wottke M, Thielmann M, et al. Re-
pair of interrupted aortic arch: results after more than 20 years. Ann Thorac Surg.
2000;70:1896-900.
8. Vouhe PR, Mace L, Vernant F, Jayais P, Pouard P, Mauriat P, et al. Primary
definitive repair of interrupted aortic arch with ventricular septal defect.
Eur J Cardiothorac Surg. 1990;4:365-70.
9. Celoria GC, Patton RB. Congenital absence of the aortic arch. Am Heart J. 1959;
58:407-13.
10. Brown JW, Ruzmetov M, Okada Y, Vijay P, Rodefeld MD, Turrentine MW. Out-
comes in patients with interrupted aortic arch and associated anomalies: a 20-
year experience. Eur J Cardiothorac Surg. 2006;29:666-74.
11. Odim JN, Laks H, Drinkwater DC Jr, George BL, Yun J, Salem M, et al. Staged
surgical approach to neonates with aortic obstruction and single-ventricle phys-
iology. Ann Thorac Surg. 1999;68:962-8.
12. Sell JE, Jonas RA, Mayer JE, Blackstone EH, Kirklin JW, Castaneda AR. The
results of a surgical program for interrupted aortic arch. J Thorac Cardiovasc
Surg. 1988;96:864-77.
13. Serraf A, Lacour-Gayet F, Robotin M, Bruniaux J, Sousa-Uva M, Roussin R,
et al. Repair of interrupted aortic arch: a ten-year experience. J Thorac Cardio-
vasc Surg. 1996;112:1150-60.
14. Jonas RA, DiNardo JA. Comprehensive Surgical Management of Congenital
Heart Disease. London, England: Oxford University Press; 2004.
15. Monro JL, Delany DJ, Ogilvie BC, Salmon AP, Keeton BR. Growth potential in
the new aortic arch after non-end-to-end repair of aortic arch interruption in in-
fancy. Ann Thorac Surg. 1996;61:1212-6.
16. Sakai T,Miki S, Ueda Y, Tahata T, Ogino H,Morioka K, et al. Left main bronchus
compression after aortic reconstruction for interruption of aortic arch. Eur J Car-
diothorac Surg. 1995;9:667-9.
17. Mishra PK. Management strategies for interrupted aortic arch with associated
anomalies. Eur J Cardiothorac Surg. 2009;35:569-76.
18. McCrindle BW, Tchervenkov CI, Konstantinov IE, Williams WG, Neirotti RA,
Jacobs ML, et al. Risk factors associated with mortality and interventions in
472 neonates with interrupted aortic arch: a Congenital Heart Surgeons Society
study. J Thorac Cardiovasc Surg. 2005;129:343-50.
19. Oosterhof T, Azakie A, Freedom RM,WilliamsWG, McCrindle BW. Associated
factors and trends in outcomes of interrupted aortic arch. Ann Thorac Surg. 2004;
78:1696-702.
20. Bergoend E, Bouissou A, Paoli F, Roullet-Renoleau N, Duchalais A, Neville P. A
new technique for interrupted aortic arch repair: the Neville tube. Ann Thorac
Surg. 2010;90:1375-6.
21. Hussein A, Iyengar AJ, Jones B, Donath SM, Konstantinov IE, Grigg LE, et al.
Twenty-three years of single-stage end-to-side anastomosis repair of interrupted
aortic arches. J Thorac Cardiovasc Surg. 2010;139:942-7, 949; discussion 948.
22. Morales DL, Scully PT, Braud BE, Booth JH, Graves DE, Heinle JS, et al. Inter-
rupted aortic arch repair: aortic arch advancement without a patch minimizes
arch reinterventions. Ann Thorac Surg. 2006;82:1577-84.rdiovascular Surgery c Volume 145, Number 1 181
Congenital Heart Disease Todman et al
C
H
D23. Mainwaring RD, Lamberti JJ. Mid- to long-term results of the two-stage ap-
proach for type b interrupted aortic arch and ventricular septal defect. Ann Thorac
Surg. 1997;64:1782-6.
24. Joynt CA, Robertson CM, Cheung PY, Nettel-Aguirre A, Joffe AR, Sauve RS,
et al. Two-year neurodevelopmental outcomes of infants undergoing neonatal
cardiac surgery for interrupted aortic arch: a descriptive analysis. J Thorac Car-
diovasc Surg. 2009;138:924-32.
25. Williams GD, Ramamoorthy C. Brain monitoring and protection during pediatric
cardiac surgery. Semin Cardiothorac Vasc Anesth. 2007;11:23-33.
26. Su XW, Guan Y, Barnes M, Clark JB, Myers JL, Undar A. Improved cerebral ox-
ygen saturation and blood flow pulsatility with pulsatile perfusion during pediat-
ric cardiopulmonary bypass. Pediatr Res. 2011;70:181-5.182 The Journal of Thoracic and Cardiovascular Surg27. Nelson DP, Andropoulos DB, Fraser CD Jr. Perioperative neuroprotective
strategies. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.
2008;49-56.
28. Visconti KJ, Rimmer D, Gauvreau K, del Nido P, Mayer JE Jr, Hagino I, et al.
Regional low-flow perfusion versus circulatory arrest in neonates: one-year neu-
rodevelopmental outcome. Ann Thorac Surg. 2006;82:2207-13.
29. Tabbutt S, Gaynor JW, Newburger JW. Neurodevelopmental outcomes after con-
genital heart surgery and strategies for improvement. Curr Opin Cardiol. 2012;
27:82-91.
30. Dominguez TE, Wernovsky G, Gaynor JW. Cause and prevention of central ner-
vous system injury in neonates undergoing cardiac surgery. Semin Thorac Cardi-
ovasc Surg. 2007;19:269-77.ery c January 2013
